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Abstract
I In nt tr ro od du uc ct ti io on n: :   The objective of this study was to assess the frequency of microal-
buminuria and the relationship with other risk factors for the development of
diabetic nephropathy.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   Our cross-section study involved a group of 60 adoles-
cence of both sexes, mean age 15.3 ﾱ2.43 years with mean duration of diabetes
7.74 ﾱ3.44 years. Albumin excretion rate was measured on 2-3 samples of the
first morning urine in the period below 6 months and persistent microalbu-
minuria was defined if its increased in two out of three urine specimens. Ambu-
latory blood pressure was monitored (ABPM, SpaceLabs 90207).
R Re es su ul lt ts s: :   Microalbuminuria developed in 13.3% of adolescents with mostly com-
pleted sexual development, statistically significantly poorer metabolic control
(9.79% vs. 8.7%) and higher BMI (23.59 kg/m2 vs. 20.85 kg/m2) than in the
patients with normoalbuminuria. The mean night-time systolic blood pressure
(SBP) was statistically significantly higher in microalbuminuric patients than in
normoalbuminurics. The nocturnal dip was reduced in 41.7% of our patients;
38.5% of nondippers were in normoalbuminuric and 62.5% in microalbuminuric
patients.
C Co on nc cl lu us si io on ns s: :   Diabetic adolescents require particular attention in order to min-
imize the factors such as high HbA1c, elevated body mass index and night-time
SBP in the development of incipient nephropathy.
K Ke ey y   w wo or rd ds s: :   microalbuminuria, ambulatory blood pressure monitoring, type 1 dia-
betes mellitus, adolescents.
Introduction
Diabetic nephropathy (DN) is one of the most serious complications of
type 1 diabetes mellitus (DM1) and one of the most common causes of
death in diabetics. The prevalence of DN among the diabetics who are
affected by DM1 in childhood and the duration of disease lasting up to 30
years is about 15% [1]. The prevalence of microalbuminuria (MA), the most
serious predictive sign of nephropathy, is 2-20% during the first 10 years
from the onset of diabetes, and about 30% at the end of the second
decade of disease duration. Microalbuminuria is rarely present during the
first 4-5 years of diabetes. The presence of albumin in urine is caused by
increased glomerular permeability and/or decreased reabsorption at the
level of the proximal tubules. To confirm MA persistence, it is necessary
to prove increased albumin excretion in two out of three urine specimens
collected over a 3-6 month period [2, 3].
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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Although there is no unique explanation for the
development of diabetic nephropathy and other
microvascular complications, there are many risk
factors that cause diabetic nephropathy or influ-
ence its progression: diabetes duration, metabolic
control, hypertension, puberty, smoking, genetic
factors, dyslipidaemia, etc. Increased blood pres-
sure probably precedes microalbuminuria develop-
ment and/or a kidney disease causing arterial
hypertension. Progressive increase in blood pres-
sure, although within the range of normal values,
can be detected before the onset of persisting
microalbuminuria, especially in adolescents with
familial hypertension [4]. Ambulatory blood pres-
sure monitoring (ABPM) is a sensitive, non-invasive
method to diagnose the earliest changes of blood
pressure in adolescents with DM1: absence of noc-
turnal dip, increased systolic and diastolic overload
(defined by the frequency of blood pressure over
the 95th percentile matched for sex and age) and
increase in mean arterial pressure [5-7]. Most like-
ly both increased urine albumin excretion and blood
pressure are manifestations of the same disease;
also hypertension may be responsible for the accel-
eration of diabetic nephropathy progression to end-
stage renal failure [8].
The aim of our study was to assess the fre-
quency of microalbuminuria in pubertal DM1 after
a period of disease remission, and to determine the
correlation between microalbuminuria and other
risk factors for diabetic nephropathy, as well as their
interrelationship: HbA1c, blood pressure, puberty,
insulin doses, body mass index (BMI), and diabetes
duration.
Material and methods
Using a cross-section study involving 60 ado-
lescents (33 females, 27 males) of mean age 15.3
ﾱ2.4 (11.0-19.7) years with DM1, with mean dis-
ease duration of 7.7 ﾱ3.4 (3.5-17.0), we evaluated
the presence of microalbuminuria. The patients
were treated at the University Children’s Hospital
of Belgrade, Serbia. All of the children were select-
ed based on the following criteria: the duration of
DM1 of over 3 years, patients aged over 11 years
with preserved global renal function and who were
not on ACE inhibitor renoprotective therapy. Mean
annual HbA1c values were determined based on
three single findings each obtained after 2-4
months. HbA1c was measured by turbidimetric
immunoassay using Beckman Synchron CX5 Clin-
ical System apparatus. In healthy persons, normal
HbA1c test results using this method range from
4.0% to 6.5%. All the patients were tested for
microalbuminuria in two out of three first morn-
ing urine samples collected within a 6-month peri-
od. Microalbuminuria was determined by the 
turbidimetric method using Architect Abbot appa-
ratus where the defined normal value was below
15 mg/l. The patients were defined as having per-
sistent microalbuminuria if the obtained values
were over 15 mg/l in two out of three samples.
Using oscillometric type of SpaceLabs 90207 units
and appropriate cuffs placed on the non-dominant
arm, ABPM was performed after obtaining the sec-
ond or third morning urine samples to assess
microalbuminuria. Systolic blood pressure, dias-
tolic blood pressure and mean arterial blood pres-
sure were recorded and analysed by the ABPM
program intended for calculating mean day-time,
night-time and 24-h values. The nocturnal dip
expressed as a percentage of mean day-time
blood pressure values was calculated using the
formula:  mean  day-time  BP-mean  night-time
BPx100%/ mean day-time blood pressure. In our
study, to assess the nocturnal dip, mean arterial
pressure values were used. The nocturnal dip was
defined as higher than 10%.
For statistical data processing in our study we
used the statistical package SPSS for Windows. The
obtained data were presented as mean ﾱ SD. The
comparison between the two independent groups
was evaluated using the independent two-sample
Student’s t-test or Mann-Whitney U-test when
appropriate. The default of ʱ < 0.05 specified the
level of significance in all of the tests. The correla-
tion between the numerical variables was calculat-
ed by Spearman’s correlation coefficient (ˁ). Uni-
variate analysis for predictors of microalbuminuria
was performed using simple logistic regression.
Results
Demographic characteristics of the patients are
presented in Table I. Eight patients (13.3%) met the
criteria for microalbuminuria. All of the adolescents
with microalbuminuria were either in stage II-IV of
puberty (25%) or had completed pubertal develop-
ment (75%). 
A significantly higher mean value of nocturnal
systolic blood pressure was observed in patients
with microalbuminuria in comparison to normoal-
buminuric patients (t = 2.161, p < 0.05). With respect
to all other BP values there was no statistically sig-
nificant difference (p > 0.05) (Table II).
We found a statistically significant correlation
between the night-time systolic BP and microalbu-
minuria,  indicating  the  association  between
increased night-time BP and urine albumin excre-
tion and vice versa (ˁ = 0.379, p = 0.00).
The duration of diabetes and insulin doses were
in a statistically significant correlation with systolic
night-time BP (ˁ = 0.313, p = 0.01; ˁ = 0.269, 
p = 0.03) and diastolic night-time BP (ˁ = 0.301, 
p = 0.02; ˁ = 0.331, p = 0.01). No correlation was
found between urine albumin excretion, the dura-
tion of diabetes, insulin doses and day-time BP .Arch Med Sci 6, December / 2011 1039
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The nocturnal dip was reduced in 41.7% of
patients; 38.5% of normoalbuminuric and 62.5% of
microalbuminuric patients were non-dippers. A sta-
tistically significant difference was found in the
mean values of patients’ ages (t = 2.124, p = 0.04)
and BMI (t = 2.643, p = 0.01) between normoalbu-
minuric and microalbuminuric patients without
a nocturnal dip of mean arterial pressure. There was
no statistically significant difference (p > 0.05)
regarding other parameters (HbA1c, duration of dia-
betes and insulin doses).
Using  univariate  logistic  regression,  in  our
patients statistically significant risk factors for the
development of microalbuminuria were high HbA1c
(hazard ratio (HR) = 1.52, 95% confidence interval
(CI): 0.97-2.40), BMI (HR = 1.26, 95% CI: 1.00-1.60)
and SBP (HR = 1.10, 95% CI: 1.00-1.20) (Table III).
Discussion
Recent extensive studies have shown a decline
in incidences of diabetic nephropathy [9, 10]. In
a study of diabetic patients aged below 18 years of
age, with diabetes duration lasting over 5 years, the
European Epidemiology Study of Diabetic Compli-
cations (EDC Study) reported a prevalence of dia-
betics with microalbuminuria of 14%, whereas in
other studies the reported prevalence of diabetics
with microalbuminuria is 2-20% [11]. In our study,
microalbuminuria  developed  in  eight  patients
(13.3%).
In DM1 prepubertal children the problem of
microvascular complications is rarely seen, in com-
parison to its rising prevalence during and after
puberty [12]. The Oxford Regional Study showed
that at initial stages of diabetes the incidence of
microalbuminuria was higher in pubertal than in
prepubertal patients [13]. These results support the
view that endocrine or metabolic factors (growth
hormone or IGF-1) can trigger or accelerate renal
damage [13]. Our microalbuminuric patients had
mean diabetes duration longer than normoalbu-
minuric patients (9.37 vs. 7.49 years) and 75% of
microalbuminuric patients were in the late puber-
tal stage. However, once puberty is achieved, the
prepubertal years of diabetes contribute as an addi-
tional risk for microalbuminuria, but longer follow-
up is needed to confirm these observations in our
study.
We assessed mean HbA1c (%) annual value as
the parameter reflecting the metabolic control of
the disease. In our patients with microalbuminuria
mean  HbA1c was  higher  (9.79%)  than  in  the
patients with normoalbuminuria (8.7%); there was
a statistically significant difference between these
two groups (p < 0.05). Other studies have also
shown that poor metabolic control is a risk factor
in the development of microalbuminuria directly
associated with hyperfiltration and renal hyper-
perfusion in early stages of DM1 [14]. It has been
confirmed that there is a linear correlation between
the onset, or progression of microalbuminuria and
P Pa ar ra am me et te er r N NA A   p pa at ti ie en nt ts s M MA A   p pa at ti ie en nt ts s
N N = =   5 52 2 N N = = 8 8
Age [years] 15.14 ﾱ2.49 16.45 ﾱ1.67
Pubertal stages 3.8/48.1/48.1 0/25/75
I/II-IV/V [%]
Insulin dose [U/kg] 1.15 ﾱ0.28 1.17 ﾱ0.05
HbA1c [%]* 8.70 ﾱ1.41 9.79 ﾱ1.64
Duration of DM [years] 7.49 ﾱ3.50 9.37 ﾱ2.57
BMI* [kg/m2] 20.85 ﾱ3.41 23.59 ﾱ3.35
AEU* [mg/l] 6.53 ﾱ3.60 22.72 ﾱ9.34
T Ta ab bl le e   I I. . Clinical characteristics of normoalbuminuric
and microalbuminuric DM1 patients
DM – diabetes mellitus, BMI – body mass index, AEU – albumin excre-
tion rate, *p < 0.05 between normoalbuminuric (NA) and microalbu-
minuric (MA) patients
B BP P   [ [m mm mH Hg g] ] N NA A   p pa at ti ie en nt ts s M MA A   p pa at ti ie en nt ts s V Va al lu ue e   o of f   p p
SBP day-time 120.23 ﾱ14.20 120.25 ﾱ7.61 1.00
DBP day-time 72.13 ﾱ7.08 70.12 ﾱ7.34 0.46
MAP day-time 88.17 ﾱ7.64 76.83 ﾱ6.38 0.43
SBP night-time 106.77 ﾱ7.93 113.62 ﾱ10.98 0.03*
DBP night-time 60.23 ﾱ6.23 62.00 ﾱ9.87 0.49
MAP night-time 75.74 ﾱ6.04 79.21 ﾱ9.28 0.32
SBP 24 h 115.25 ﾱ8.56 117.87 ﾱ8.36 0.42
DBP 24 h 68.08 ﾱ5.89 67.62 ﾱ7.91 0.85
MAP 24 h 83.80 ﾱ6.12 84.37 ﾱ7.02 0.84
T Ta ab bl le e   I II I. .   Descriptive statistical indices for day-time,
night-time and 24-h values of ABPM in patients with
and without microalbuminuria
SBP – systolic BP, DBP – diastolic BP, MAP – mean arterial pressure, 
*p < 0.05
V Va ar ri ia ab bl le e V Va al lu ue e   o of f   p p O Od dd ds s   r ra at ti io o   ( (9 95 5% %   C CI I) )
Gender 0.29 2.27 (0.49-10.53)
Age [years] 0.16 1.27 (0.91-1.77)
Pubertal stages:  0.16 3.19 (0.62-16.37)
Tanner I-III vs IV-V
HbA1c (> 7.5%) 0.04* 1.52 (0.97-2.40)
BMI [kg/m2] 0.05* 1.26 (1.00-1.60)
Systolic BP night-time  0.04* 1.10 (1.00-1.20)
[mmHg]
Diastolic BP night-time  0.49 1.04 (0.93-1.15)
[mmHg]
Insulin dose/weight  0.80 1.43 (0.09-22.11)
[U/kg]
T Ta ab bl le e   I II II I. . Results of univariate logistic regression
analysis for microalbuminuria
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HbA1c values [15]. This finding indicates that there
is no definite level of metabolic control Hb below
which metabolic complications are excluded, or
inversely, above which exponential rise can occur
in  the  development  and  the  progression  of
microvascular complications; this means that any
change of HbA1c, with respect to normal values, car-
ries a risk for the development of microalbuminuria
(and other microvascular complications) [15].
Obese children, depending on BMI increase, are
at a much higher risk of developing hyperlipidaemia
and hypertension related to BMI increase. The risk
is proportional. It should be pointed out that obese
children without diabetes more frequently have
microalbuminuria compared to children with nor-
mal weight, which indicates that the presence of
early renal glomerular and tubular dysfunction is
the consequence of obesity. From this aspect obe-
sity, i.e. increased BMI, carries a higher risk of sim-
ilar disorders developing in children with DM1 [16].
Our patients with normoalbuminuria had a BMI of
20.85 kg/m2, whereas the patients with microal-
buminuria had a statistically significantly higher
BMI (23.59 kg/m2, p < 0.05).
Using ABPM, a non-invasive method, it was pos-
sible to detect the earliest BP changes in adoles-
cents with DM1. In our group, the mean value of
night-time systolic BP was statistically significant-
ly higher in the patients with microalbuminuria than
in those with normoalbuminuria (p < 0.05), where-
as a statistically significant difference was not found
in other mean blood pressure values. Regarding sys-
tolic blood pressure during sleep, we obtained sim-
ilar results to that of Spanish authors who report-
ed a significant correlation between the night-time
systolic BP increase and the development and pro-
gression of microalbuminuria, also indicating that
each 5 mmHg increase of systolic blood pressure
resulted in 1.4 times higher increase of urine albu-
min excretion [17]. Blood pressure increase, espe-
cially night-time systolic blood pressure, is associ-
ated with intrarenal haemodynamic changes that
can cause incipient and clinically evident diabetic
nephropathy [17]. Accordingly, we found a statisti-
cally highly significant relation between the night-
time blood pressure and albuminuria in our group
of patients. Elevations of night-time BP even with-
in the normal range appear to increase the risk for
development of diabetic nephropathy.
Urine albumin excretion progresses with dia-
betes, and likewise a prolonged duration of diabetes
leads to the progression of increase in blood pres-
sure [18]. Based on our results, it is evident that the
duration of diabetes is statistically significantly
associated with night-time systolic and diastolic
blood pressure (p < 0.05). Most authors consider
that, although within the normal value range, the
progressive increase of blood pressure can be
detected prior to the development of persistent
microalbuminuria [19]. Our study also shows that
higher insulin doses were associated with higher
levels of night-time systolic and diastolic blood pres-
sure. Insulin may induce sodium retention, which
may lead to an increase in blood pressure [18].
Future studies will need to consider whether insulin
therapy underlies blood pressure changes. In addi-
tion, consideration should be given to whether
short-term changes in glycaemic control or insulin
dose lead to corresponding changes in night-time
blood pressure.
The absence of a normal nocturnal dip is a sign
of the first noticeable cardiovascular disorder. In
healthy individuals a blood pressure decline of at
least 10% occurs during night-time [20]; otherwise,
the person could be exposed to a higher risk of tar-
get organ damage [20]. In a three-year prospective
study Poulsen et al. showed that DM1 children with
microalbuminuria developing prior to the onset of
incipient nephropathy had a milder BP decline in
comparison with diabetic children without microal-
buminuria  [21].  It  is  still  unclear  whether  the
absence  of  nocturnal  non-dipping  precedes
increased blood pressure during sleep, or whether
its development occurs concomitantly with blood
pressure increase; however, nocturnal non-dipping
is doubtlessly associated with changes in renal mor-
phology and it is an early predictor of diabetic
nephropathy [21]. In our study of children with DM1,
in as many as 41.7% the nocturnal dip was absent,
which could be a potential marker of an emerging
disorder involving the presence of new complica-
tions in a significant number of our patients. In chil-
dren with microalbuminuria the problem was even
more frequent, being present in 62.5% of cases,
whereas in children with normoalbuminuria it was
present in 38.5% of cases. When comparing the
normoalbuminuric non-dipping children with the
microalbuminuric non-dippers, the following sta-
tistically significant differences could be detected:
age and BMI were significantly different in children
with microalbuminuria (16.9 years vs. 14.6 years;
24.62 kg/m2 vs. 20.49 kg/m2). The non-dipping chil-
dren with microalbuminuria had poor metabolic
control in comparison with the non-dipping chil-
dren with normoalbuminuria (9.59% vs. 8.79%), but
the difference was not statistically significant.
The prevention of diabetic nephropathy is aimed
at early recognition of numerous risk factors that
could affect the development of persistent microal-
buminuria. In the present study, we have shown
that microalbuminuric patients differed from the
normoalbuminuric subjects in having higher HbA1c,
higher BMI and higher systolic night-time blood
pressure. Also, the absence of a drop in nocturnal
blood pressure has been emphasized in microal-
buminuric patients. Our data suggest that the pre-Arch Med Sci 6, December / 2011 1041
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vention of diabetic nephropathy should be direct-
ed toward prevention of obesity and improvement
of metabolic control, applying a complex approach
when treating adolescent diabetics; thus, it is rec-
ommended that HbA1c in childhood should be
below 7.5%. In addition, elevations in nocturnal
blood pressure could be an important initiating fac-
tor of diabetic nephropathy. Ambulatory 24-h meas-
urement can improve the detection of a mild
increase in blood pressure concurrent with the
development of early diabetic nephropathy.
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